Sign In
Buy OCGN
$1.22
+0.0100 (+0.83%)
At Close: Jun 15, 2026
OCGN Stock: Why It Significantly Increased Today
12:34pm, Monday, 13'th Sep 2021
The stock price of Ocugen Inc (NASDAQ: OCGN) significantly increased during intraday trading. This is why it happened.
Ocugen, Inc. to Present at Upcoming Citi and H.C. Wainwright Investment Conferences
05:22pm, Tuesday, 07'th Sep 2021
MALVERN, Pa., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc . (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness dis
This 28% Short Biotech Company Has A Better 1-Year Return Than AMC, Snap, Apple And Tesla
01:08pm, Tuesday, 07'th Sep 2021
An investment in Ocugen Inc (NASDAQ: OCGN) one year ago is undoubtedly a sight for sore eyes. Since January 2021, Ocugen stock's year-to-date return has outperformed a number of the world's most popul
Ocugen Should Hit $9 If Its Covid-19 Vaccine Gets Approved
10:18am, Wednesday, 01'st Sep 2021
Ocugen still hopes its Covid-19 vaccine gets approved to start making revenue. OCGN-stock could be worth as much as $9.09 or 19% over today's price assuming its Covid-19 vaccine gets approval.
Ocugen Stock Will Suffer Its Inevitable Demise Sooner Rather Than Later
06:27am, Wednesday, 01'st Sep 2021
It may take time for it to experience its ultimate collapse. But as its still a matter of if rather than when?
Ocugen Stock Seems Unattractive With Regulatory Uncertainties
01:33pm, Tuesday, 31'st Aug 2021
OCGN stock is unattractive as regulatory approval delays have limited the revenue and cash flow potential for the Covid-19 vaccine. The post Ocugen Stock Seems Unattractive With Regulatory Uncertainti
Ocugen Stock Doesn't Have Short-Term Catalysts Needed To Make It a Buy
06:30am, Monday, 30'th Aug 2021
OCGN stock is interesting once again as concerns regarding the Delta variant mount. But that should not be your sole reason to invest in Ocugen.
The Odds Are Firmly Against Ocugen Stock Now
02:55pm, Friday, 27'th Aug 2021
OCGN stock is a remarkably risky Covid-19 vaccine play, as the company faces a myriad of regulatory roadblocks on different fronts. The post The Odds Are Firmly Against Ocugen Stock Now appeared first
Ocugen's Facing a Major Uphill Climb Without FDA Approval
03:22pm, Monday, 23'rd Aug 2021
The quick FDA approval of Ocugen's Covid-19 vaccine is fading with every passing day. As a result, OCGN stock is down 17% in the past week.
Ocugen Stock Is Well-Positioned, But Investors Want Results
03:12pm, Monday, 23'rd Aug 2021
The company's latest business update sounds all fine and good, but OCGN stock holders want to see some action, not just words. The post Ocugen Stock Is Well-Positioned, But Investors Want Results appe
Ocugen Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:34pm, Friday, 20'th Aug 2021
MALVERN, Pa., Aug. 20, 2021 (GLOBE NEWSWIRE) -- Ocugen, Inc. (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness disea
Ocugen Stock Remains an All or Nothing Wager You Shouldn't Make
06:00am, Friday, 20'th Aug 2021
In so many words, the story's unchanged with OCGN stock. An all or nothing bet, with more pointing to "nothing," it's still best to stay away.
Los Angeles, California--(Newsfile Corp. - August 17, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ocugen, Inc. ("Ocu
New York, New York--(Newsfile Corp. - August 17, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Ocugen, Inc. (NASDAQ: OCGN) alleging tha
New York, New York--(Newsfile Corp. - August 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities o
